HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases

被引：16
作者：
Zhang, Han [1 ]
Ren, Guoping [1 ]
Wang, Xiaoling [1 ]
Zhao, Jing [1 ]
Yao, Hongtian [1 ]
Bai, Yanfeng [1 ]
Bo, Wang [1 ]
机构：
[1] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2012年 / 134卷 / 02期
基金：
匈牙利科学研究基金会;
关键词：
Breast cancer; Fluorescence in situ hybridization; HER-2/neu; PROGESTERONE-RECEPTOR GENE; INTEROBSERVER REPRODUCIBILITY; PROTEIN OVEREXPRESSION; ESTROGEN; EXPRESSION; ANEUSOMY; TISSUE;
D O I：
10.1007/s10549-012-2101-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The concordance rate between fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) on evaluating HER-2/neu status is still controversial, especially for the IHC 2+/equivocal cases. In this study, we investigated the amplification of HER-2/neu gene by FISH in IHC (2+)/equivocal specimens to clarify the correlation between HER-2/neu and clinicopathologic features of breast cancers. HER-2/neu amplification was determined by FISH on 528 specimens of breast carcinomas with equivocal expression of HER-2/neu protein by IHC detection. 65.5 % of IHC 2+ patients were negative for HER-2/neu amplification, 29.0 % were positive and the remaining was equivocal. A statistically significant inverse association was found between hormone receptor expression and HER-2/neu amplification (P < 0.05). Furthermore, polysomy of CEP17 was detected in 60 % of breast carcinomas. The results highlight the necessity of FISH test for further categorization when breast carcinoma cases are scored 2+ by IHC.
引用
收藏
页码：743 / 749
页数：7
相关论文
共 30 条
  • [1] Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    Arpino, G
    Weiss, H
    Lee, AV
    Schiff, R
    De Placido, S
    Osborne, CK
    Elledge, RM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17): : 1254 - 1261
  • [2] Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: An interphase cytogenetic study
    Botti, C
    Pescatore, B
    Mottolese, M
    Sciarretta, F
    Greco, C
    Di Filippo, F
    Gandolfo, GM
    Cavaliere, F
    Bovani, R
    Varanese, A
    Cianciulli, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 190 (05) : 530 - 539
  • [3] A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution
    Crowe, Joseph P.
    Patrick, Rebecca J.
    Rybicki, Lisa A.
    Escobar, Pedro F.
    Weng, David
    Budd, G. Thomas
    Tubbs, Raymond R.
    Procop, Gary W.
    Hicks, David G.
    [J]. BREAST, 2006, 15 (06) : 728 - 735
  • [4] Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
    Dal Lago, Lissandra
    Durbecq, Virginie
    Desmedt, Christine
    Salgado, Roberto
    Verjat, Thibault
    Lespagnard, Laurence
    Ma, Yan
    Veys, Isabelle
    Di Leo, Angelo
    Sotiriou, Christos
    Piccart, Martine
    Larsimont, Denis
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (10) : 2572 - 2579
  • [5] The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study
    Downs-Kelly, E
    Yoder, BJ
    Stoler, M
    Tubbs, RR
    Skacel, M
    Grogan, T
    Roche, P
    Hicks, DG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1221 - 1227
  • [6] Elledge RM, 1998, CLIN CANCER RES, V4, P7
  • [7] Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization
    Hammock, L
    Lewis, M
    Phillips, C
    Cohen, C
    [J]. HUMAN PATHOLOGY, 2003, 34 (10) : 1043 - 1047
  • [8] HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
    Hoang, MP
    Sahin, AA
    Ordòñez, NG
    Sneige, N
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) : 852 - 859
  • [9] Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related
    Huang, HJ
    Neven, P
    Drijkoningen, M
    Paridaens, R
    Wildiers, H
    Van Limbergen, E
    Berteloot, P
    Amant, F
    Christiaens, MR
    Vergote, I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 91 (01) : 81 - 87
  • [10] HER2-testing in 538 consecutive breast cancer cases using FISH and immunohistochemistry
    Kovacs, Aniko
    Stenman, Goeran
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (01) : 39 - 42
123